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ABSTRACT 
OBJECTIVE: The objective of this selective EBM review is to determine whether honey used as 
adjunctive therapy is effective in alleviating nasal allergy symptoms. 
STUDY DESIGN: This is a systematic review of three randomized controlled trials published 
between 2010-2013, all in the English language.  
DATA SOURCES: Three randomized controlled trials, which studied the effects of honey used 
as adjunctive therapy for the relief of nasal allergy symptoms, these were obtained using 
PubMed.  
OUTCOMES MEASURED: The outcome of each study was a patient reported decrease in the 
number of days and the severity of nasal allergy symptoms including: sneezing, itching, nasal 
blockage, and rhinorrhea. These outcomes were measured via daily diary entries, questionnaires 
regarding symptom severity and need for medication, Sino-Nasal Outcome Test (SNOT-22) 
questionnaire, and a 7-point visual analog symptom severity scale. 
RESULTS: All three RCTs determined that nasal allergy symptoms were decreased a 
statistically significant amount, as defined by a p-value <0.05, with the addition of honey in 
subject’s daily medication regimen. This was compared to control, which consisted of patients 
taking only their normal daily medication and no honey products or a visually and taste matched 
placebo. 
CONCLUSIONS: The results of this systematic review have demonstrated that honey is 
effective in alleviating nasal allergy symptoms in numerous mediums including nasal spray as 
well as oral intake when produced in the geographic area in which the patient population resides. 
Whilst positive and promising results were obtained from these studies, additional research with 
larger patient populations, standardized honey product, and increased time frame of study is 
required to ascertain how beneficial honey truly is and if these benefits last. 
KEY WORDS: honey, allergic rhinitis
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INTRODUCTION:  
The number of people worldwide who suffer from allergies is steadily increasing; 
whether it be from air pollution, improved hygiene, or increased indoor allergen exposure, the 
exact cause for this escalation remains unknown.1 Allergic rhinitis, also identified as “allergic 
rhinosinusitis” or “AR,” is an extremely common disorder affecting upwards of 40 million 
people in the U.S.2  It is reported that AR is the cause of, “at least 2.5 percent of all clinician 
visits, 2 million lost school days, 6 million lost work days, and 28 million restricted work days 
per year.” 3  Currently, AR affects 10-30% of children and adults in the U.S., making it inevitable 
that healthcare providers will encounter this disease.3   
AR is attributable to a host of triggers including: pollen, mold, animal dander, and dust 
mites. When allergy sufferers encounter an allergen, the immune system produces antibodies, 
immunoglobulin E (IgE), to the allergen.4  IgE antibodies bind with mast cells, plasma cells and 
eosinophils, which within minutes produce symptoms such as sneezing and itching.2  Hours later, 
the late phase of reaction occurs producing nasal congestion and malaise.2  AR comprises 
numerous symptoms including: sneezing, itching, nasal congestion, and rhinorrhea. As the nasal 
mucosa and the sinuses are adjoining, patients with sinusitis also concomitantly experience nasal 
symptoms.3  AR may affect sufferers in a seasonal pattern or for many, is a constant year-round 
struggle. For something as trivial in many people’s minds as “seasonal allergies,” the cost to 
manage this disease has become astronomical. In February 2011, it was reported that 
approximately $3.4 billion were spent on allergic rhinitis with almost half due to the cost of 
prescriptions and over the counter medications.5 Furthermore, research has shown sufferers of 
AR have an average number of prescriptions double that of non-sufferers.3   With this being said, 
cost effective alternative methods have become a necessity. 
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There are numerous accepted methods used to treat the myriad of symptoms comprising 
allergic rhinitis. First and foremost, allergen avoidance is encouraged.6 However, since it is near 
impossible to avoid pollen, fungus, mold, or dust in the air, other options must be employed to 
combat the immune system’s exaggerated response. For suffers with mild or episodic symptoms, 
oral second-generation antihistamines including cetirizine, loratadine, fexofenadine are 
effective.6  Gold standard treatment for persistent or moderate to severe AR is glucocorticoid 
nasal sprays including: mometasone furoate, fluticasone furoate, and triamcinolone acetonide.6 
In addition to an oral second-generation antihistamine or a glucocorticoid nasal spray, patients 
can augment their treatment by adding: antihistamine nasal sprays such as olopatadine or 
azelastine, a mast cell stabilizer such as Cromolyn sodium, an anti-leukotriene such as 
Montelukast, or combination products consisting of an oral antihistamine plus a decongestant.6 
More expensive and time consuming yet, is allergen immunotherapy. As many of the above-
mentioned products are now over the counter, patients have the ability to self-medicate, and this 
comes with risks. Many of these products can be sedating, especially if a patient chooses a first-
generation antihistamine for example, diphenhydramine.  Due to their anti-cholinergic properties 
these medications can cause urinary retention, altered mental status or confusion, blurred vision, 
dizziness, and other adverse drug reactions.6  
The usual methods of treatment discussed for nasal allergy symptoms while effective, 
have potentially adverse side effects or undesirable dosing schedules, which limit their use in 
certain patients; in addition, maximum relief is often never achieved. This leaves patients to 
continue to battle daily with their symptoms and search for other options. One of these suggested 
options, a natural and safe alternative, is honey. Honey has been recognized as an antioxidant, 
antibacterial, antiviral, anti-inflammatory, and immunomodulating substance.7 The proposed use 
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of honey is supported by its immunomodulation and anti-inflammatory properties. In animal 
studies, honey has been proven to reduce circulating IgE levels, suppress histamine release, 
prevent the production of TNF-α and COX-2, and reduce the creation of nitric oxide.7,8 With the 
rising costs of healthcare and the wide availability of natural alternatives, it is proposed that 
honey be considered as a cost-effective alternative adjunctive method to patient’s normal daily 
medication regimen in relieving nasal allergy symptoms. In this systematic review, the 
effectiveness of honey in decreasing nasal allergy symptoms will be evaluated through three 
randomized controlled trials.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not honey, as 
adjunctive therapy, is effective in alleviating nasal allergy symptoms. 
METHODS  
The population studied in this systematic review was obtained from three randomized 
controlled trials which included patients suffering from physician diagnosed nasal allergy 
symptoms. Oral consumption of honey or inhalation of honey solution in addition to the patient’s 
traditional allergy medication regimen were the interventions reviewed. In Asha'ari et al. 
patients, minimum of 18 years of age, were treated with a second generation antihistamine 
(Loratidine 10mg) for 4 weeks.8 Loratidine was then discontinued for the remaining 4 weeks of 
the study and was replaced with honey or placebo. The case group was given Tualang honey, 
raw and unprocessed, and the control a honey flavored corn syrup as placebo to be ingested at 1g 
per kg of body weight.8  Thamboo et al. had subjects, 19 years of age and up with a diagnosis of 
allergic fungal rhinosinusitis who had failed standardized treatment methods, spray 2mL of a 
50/50 mixture of honey and saline into one nostril nightly with a mucosal atomization device. 
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The other nostril, which received no honey spray, was utilized as the control; this solution was in 
addition to their usual daily medication regimen for 30 days.9  Saarinen et al. compared two 
types of honey: a locally collected, unpasteurized and unfiltered organic honey (“regular honey” 
or “RH”) against the very same honey enriched with bee-collected pollen from Birch trees, 
deemed “Birch pollen honey” (“BPH”) versus control, which consisted of patients on their 
regular allergy medication.10 Patients were instructed to ingest the honey daily starting in 
November at <1g and increasing the dose at 3 week intervals to a maximum of 8g until the end 
of March.10  Reduction in nasal allergy symptoms was the result assessed in each study. 
The key words employed in the author’s search for sources via PubMed included 
“honey,” and “allergic rhinitis.” Articles utilized in this systematic review were selected from 
published peer- reviewed journals in the English language. Articles were chosen if they included 
outcomes which were patient oriented (POEMs) and if they related to the author’s clinical 
question. Articles selected fit the inclusion criteria of: randomized controlled trials published 
after 2010 with no other systematic review, meta-analysis, or articles published in the Cochrane 
database regarding the same clinical question. Exclusion criteria consisted of any patient with a 
known hypersensitivity to bees or honey. Noted statistics include p-value, mean change from 
baseline, and standard deviation. 
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Table 1: Demographics and Characteristics of Included Studies  
 
Study Type # 
Pts 
Age 
(years) 
Inclusion Criteria Exclusion 
Criteria 
W/D Interventions 
Asha'ari, 
2013 
RCT 40 20-50 Patients 18 years 
+  with a 
diagnosis of 
allergic rhinitis 
using clinical 
history and 
positive skin 
prick test. Must 
be 
willing to 
consume a 
considerable 
amount of honey. 
 
Known 
hypersensitivity 
to honey, history 
of asthma, 
diabetes, or other 
chronic illness, 
history of allergy 
desensitization 
for the past 5 
years, or  
pregnancy. 
Not 
reported 
1g/kg of 
Tualang 
honey daily 
in separate 
doses for four 
weeks in 
addition to 
10mg of 
Loratadine. 
 
Thamboo, 
2011 
RCT 38 19+ Patients who had 
undergone 
bilateral 
functional 
endoscopic sinus 
surgery with a 
definitive 
diagnosis of 
allergic fungal 
rhinosinusitis 
who failed 
budesonide 
irrigations for <12 
weeks and have 
tried a course of 
systemic 
antifungals and 
steroids. 
Patients allergic 
to pollen, honey, 
or bees. 
4 2mL nasal 
spray of 
50/50 honey-
saline 
solution using 
a mucosal 
atomization 
device in 
selected 
nostril once a 
day (at night) 
for 30 days in 
addition to 
regular nasal 
regimen. 
Saarinen, 
2010 
RCT 61  8-79 Patients with 
physician 
diagnosed pollen 
allergy suffering 
from nasal, 
conjunctival, and 
other allergy 
symptoms. 
No mentioned 
exclusion 
criteria. 
 
11 Each patient 
consumed 
honey on a 
daily basis 
starting with 
<1g in 
November 
and 
increasing 
intake to 1 tsp 
(about 8g) 
until the end 
of March. 
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OUTCOMES MEASURED:  
In this review three RCTs were employed, two single blind and one double blind, with 
the measured outcomes being POEMs. The POEMs measured in this review were improvement 
(reduction) of allergic nasal symptoms including: sneezing, nasal obstruction, rhinorrhea, 
hyposmia, and nasal itching as well as decreased need for usual medication. This was ascertained 
using diary entries including daily symptom severity, questionnaires regarding symptoms and 
need for medication, Sino-Nasal Outcome Test (SNOT-22) questionnaire, and a 7-point visual 
analog scale to evaluate symptom severity score. All data was continuous and was statistically 
measured by means of the patient’s self-reported decrease in nasal allergy symptoms or 
decreased need for daily medication displayed as mean change from baseline and p-values 
assessed against the control group for comparison. 
RESULTS: 
To determine if the effect of honey on nasal allergy symptoms was advantageous the 
three articles being evaluated in this systemic review claimed a statistically significant outcome 
was obtained if the consequential p-value was <0.05. The data statistically analyzed from all 
three studies was continuous, therefore a mean change in baseline was reported.  In Asha'ari et 
al. no significant differences were reported between the experimental and control groups in terms 
of the mean total symptom score (i.e. the severity of symptoms) at the onset of the study as well 
as no significant differences between the groups according to demographics. Forty patients were 
utilized and were split evenly between control and experimental arms of the study.8  Reported 
time intervals were from weeks 0-4, weeks 4-8, and weeks 0-8.8  Those patients in the 
experimental group reported statistically significant decreases in their nasal allergy symptoms 
from weeks 0-4, 4-8, and 0-8 as demonstrated in tables 2, 3, 4 and 5.8  In contrast, the control 
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arm (placebo) also noted a statistically significant decrease in nasal allergy symptoms from 
weeks 0-4; however, from weeks 4-8 there was no longer any noteworthy reduction reported.8 In 
this study, we focus on weeks 4-8, which highlights singularly the use of honey versus placebo. 
Table 2: Mean total symptom score comparison between experimental arm and control 8 
Week Difference in total symptom 
score: Experimental 
P- value: 
Experimental 
Difference in total 
symptom score: Control 
P- value: 
Control 
0-4 3.05 (4.76) 0.010 2.10 (4.15) 0.036 
4-8 2.30 (3.28) 0.005 1.03 (3.54) 0.209 
0-8 5.35 (4.98) 0.000 3.13 (4.10) 0.003 
Table 3: Change in mean from baseline symptom severity score from weeks 0-4 8 
Symptom Experimental Mean 
difference (SD) 
P- value Control Mean 
difference (SD) 
P- value 
Nasal itchiness 0.45 (0.95) 0.046 0.45 (1.19) 0.107 
Sneezing 0.48 (0.88) 0.031 0.23 (0.84) 0.244 
Nasal blockage 0.42 (0.95) 0.043 0.19 (0.44) 0.121 
Rhinorrhea 0.38 (0.44) 0.063 0.56 (0.78) 0.052 
 
Table 4: Change in mean from baseline symptom severity score from weeks 4-8 8 
Symptom  Experimental Mean 
difference (SD) 
P- value Control Mean 
difference (SD) 
P-value 
Nasal itchiness 0.30 (0.47) 0.010 0.10 (0.64) 0.494 
Sneezing 0.32 (0.89) 0.047 0.18 (0.54) 0.124 
Nasal blockage 0.39 (0.78) 0.04 0.39 (0.87) 0.087 
Rhinorrhea 0.25 (0.49) 0.112 0.14 (0.38) 0.135 
 
Table 5: Change in mean from baseline symptom severity score from weeks 0-8 8 
Symptom  Experimental Mean 
difference (SD) 
P- value Control Mean 
difference (SD) 
P-value 
Nasal itchiness 0.75 (0.97) 0.03 0.55 (0.94) 0.17 
Sneezing 0.80 (1.32) 0.025 0.41 (0.74) 0.045 
Nasal blockage 0.81 (1.11) 0.021 0.58 (1.01) 0.115 
Rhinorrhea 0.63 (0.72) 0.044 0.70 (0.72) 0.77 
 
Thamboo et al. utilized honey as a nasal spray for patients with nasal allergy symptoms 
due to allergic fungal rhinosinusitis. Subjective nasal allergy symptoms were recorded via the 
Sino-Nasal Outcome Test (SNOT-22) pre and post study (4 weeks in length).9  Out of the 38 
subjects involved in this study, 20 completed both the pre and post SNOT-22 questionnaire. A 
significant improvement in  nasal allergy symptoms was expressed by sixteen out of the twenty 
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patients in this study, as evidenced by a p-value of 0.0220.9  In this trial, four patients claimed 
“burning sensation” in their sinuses however, this did not alter their compliance with the study, 
and one patient claimed the honey solution induced nausea and subsequently discontinued 
participation in the study.9  
Saarinen et al. divided subjects into 3 groups: control receiving no honey products, those 
receiving birch pollen honey (BPH), and those receiving regular honey (RH).10 Here, we focus 
on the BPH group. Patients were given diaries in which daily recordings of: sneezing, runny, 
itchy, or blocked nose were documented. Patients were additionally responsible for a 
questionnaire which rated daily symptoms and need for medication. Of the original 61 subjects 
in this study, 11 dropped out.10  Subjects in the BPH group demonstrated increased days 
symptom free, decreased days with nasal symptoms, and decreased need for nasal medication 
compared to control. In regard to symptomatic days, the BPH group had the most significant 
change, p-value < 0.01.10  Those patients in the BPH group also showed a statistically significant 
decrease in the need for nasal antihistamines p-value <0.001 when compared to control.10 See 
Table 6 for results. 
Table 6: Number of days with allergy symptoms and use of nasal antihistamine 
medication10  
# of days BPH RH Control P-value 
Symptom free  32.1 + 14.2 26.6 + 16.5 14.1 + 12.6 0.004 
Nasal symptoms 23.0 + 12.9 29.8 + 20.5 44.2 + 12.3 0.001 
Use of nasal spray 8.0 + 13.5 13.4 + 23.4 19.5 + 22.0 0.247 
 
In addition, “better general health” and a reduction in number of colds and stomach upset was 
reported by 35% of those who used the birch pollen honey and 38% in the regular honey group.10 
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DISCUSSION: 
Honey is a reasonably safe adjunctive method to augment the treatment of nasal allergy 
symptoms. In the three articles discussed, minimal side effects were mentioned including: mild 
itching of mouth or skin, dislike for taste, burning sensation in the sinuses, and nausea.8,9,10 
However, it should be noted that those who suffer from allergy to bees or honey should not 
incorporate this therapy into their daily routine due to the risk of anaphylaxis.10 Patients are also 
advised to never administer honey products to children less than one year in age due to the risk 
of botulism. If patients choose to utilize honey as adjunctive therapy they unfortunately would 
have to pay for it out of pocket, potentially limiting access to this method of care. However, 
depending on where the honey is purchased, it is relatively low in cost when compared to the 
price of standard allergy medications. The studies discussed in this systematic review establish 
the potential worth as well as the effectiveness of utilizing honey as an adjunctive therapy in 
reducing nasal allergy symptoms. While all three of these studies demonstrated a statistically 
significant reduction in symptoms, there are limitations to each. 
In Asha'ari et al. the improvement demonstrated in both the control and experimental 
groups from week 0-4 can be attributed to the use of Loratidine during this time.8 However, the 
data displays patients in the control arm of the study no longer had any improvement of their 
symptoms in the subsequent weeks (as Loratadine was discontinued in both groups at week 4). 
This suggests that the use of honey unaided in the experimental group from weeks 4-8 was 
effective in reducing patient’s symptom severity score.8  The strength of this study was that it 
utilized honey alone as treatment after week 4, thus any improvement in symptoms is credited to 
the use of honey. The downfall of this study was the small patient population utilized, 20 
subjects in the experimental group and 20 in control.8  
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Thamboo et al. demonstrated that nasal inhalation of a honey-saline mixture did produce 
a statistically significant improvement in allergic nasal symptoms in those patients who filed a 
SNOT-22 questionnaire pre and post-study.9 This study is limited by the fact that patients acted 
as their own control, therefore the improvement in their symptoms could be attributed to the fact 
that patients were not truly blinded.9 In addition, this study was thirty days in length. Most 
notably, the questionnaire utilized incorporated other allergic symptoms therefore a decrease in 
the total score could have been due to improvement of symptoms other than nasal. Regardless, 
inhalation of the honey saline solution did improve symptom severity and this warrants deeper 
investigation. If this study was expanded to include a larger patient population, the length of the 
study was increased, and a more accurate way to blind patients was instilled, a more reliable 
interpretation of the effect of honey on nasal symptom severity could be obtained. 
Saarinen et al. established that the use of either regular honey or birch pollen honey 
resulted in less need for nasal antihistamine spray, fewer days with nasal symptoms, and 
increased number of symptom free days.10 All of which had statistically significant results. The 
strength of this study was that it utilized a “preloading period” in which patients consumed 
honey in five preseason months, November through March.10 This study highlights the benefit of 
augmenting natural raw honey with additional pollen as demonstrated by subjects decreased 
symptoms and reduced need for nasal antihistamines. The extended length of this study allows 
one to deduce the potential benefits of honey employed as natural allergen desensitization.10  
Limitations of this study are that both the experimental groups contained more patients than 
control; BPH group: 25 patients, RH: 19 patients, control: 17 patients.10  This could have skewed 
statistics in favor of the experimental groups. This study also employs a relatively small patient 
population. 
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The outcomes of these three studies are limited as the type of honey used was not 
standardized, therefore the results could be said to only apply to that one particular type of honey 
in that one specific location. Therefore, sufferers of nasal allergy symptoms can find relief in 
using honey produced in their geographic area of residence. The time period in which honey was 
administered to patients also affects the outcome of this review. In order to validate the use of 
honey as adjunctive therapy, a specific time period in which honey is administered would need to 
be regulated. There were also numerous approaches taken in which patients rated the severity of 
their symptoms, if a universal method to score symptom severity were utilized, a more 
conclusive, standardized result could be obtained. 
CONCLUSION: 
The conclusion deduced from these three studies is that honey is a safe and effective 
adjunctive method of reducing the severity of nasal allergy symptoms in suffers of the same 
geographic area in which the honey was produced.  A statistically significant decrease in 
symptom severity was achieved in patients who used honey in addition to their routine allergy 
medication regimen in all three studies. In order to entirely validate the effectiveness and the 
success of honey in reducing nasal allergy symptoms, more research would need to be completed 
with a greater patient population. Furthermore, it would be advantageous to perform additional 
research on the time frame in which patients employ the addition of honey into their daily 
routine. This could demonstrate if there is increased effectiveness in “preloading” the body prior 
to allergy season for those who specifically suffer from seasonal allergies. It would also be 
advantageous to research the potential long-term benefits of honey use, if any exist. 
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